tirzepatide phase 3 study results SURMOUNT-3: shows total mean weight loss of 26.6% from entry over 84 weeks tirzepatide phase 3 trial 80

These side effects could be bothersome, especially when youre already dealing with symptoms like fatigue and joint pain

Impact of loop diuretic on outcomes in patients with heart failure and reduced ejection fraction

This article explains what is currently known about retatrutide's cardiac effects and who should exercise particular caution

Even though semaglutide is often a valuable addition to a weight loss regimen, it is important to stay physically active and continue to eat healthy, nutritious foods throughout the whole processeven after you stop taking the medication

Oral semaglutide (Rybelsus) is taken once daily as a tablet